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Abstract
Background: Counselling on health-related lifestyles is key to the prevention and management of chronic diseases.
After comprehensive study of determinants of its delivery in general practice and strategies to improve, we composed
a tailored improvement program, which included communication skills training, online patient information, and a
clinical protocol for managing depressive symptoms. Our aim was to assess the effectiveness of this program on
professional performance and outcomes in cardiovascular patients.
Methods: A two-arm cluster randomized trial in 34 general practices involving 34 nurses was conducted. The primary
outcome was an aggregated score of a positive score on lifestyle counselling delivered and an appropriate action on
depressive symptoms. Secondary outcomes included the various elements of the primary outcome, vascular risk factors
(extracted from patient records), and patient-reported lifestyle behaviors. Data were collected from medical records and
a written survey among included patients.
Results: A sample of 1782 patients with recorded cardiovascular disease or high cardiovascular risk was available at
follow-up at 6 months. No impact on the primary outcome was found; lifestyle counselling was recorded in a minority
of patients (11.4 % in the intervention group and 10.3 % in the control group). An effect was found on a secondary
outcome: patients’ physical activity level increased (B 0.18; 95 % CI 0.02–0.35) on a seven-point scale.
Conclusions: The tailored improvement program showed no effect on the primary outcome. This challenges the
methodology of tailoring. More involvement of the targeted health care professionals might offer ways to develop
more effective implementation programs. Physical activity might be the lifestyle issue that can be more easily changed
than smoking or dietary habits.
Trial registration: Nederlands Trial register NTR4069
Keywords: Implementation, Tailored interventions, Cardiovascular disease, Risk factors, Primary care, Lifestyle,
Counselling, Randomized controlled trial, Cluster randomization
Background
Atherosclerosis-related disease is increasingly prevalent as
a result of aging populations, unhealthy lifestyles, and sur-
vival of patients with potentially lethal cardiovascular dis-
eases (CVD) after effective treatment. Clinical guidelines
on cardiovascular risk management (CVRM) provide clear
recommendations on risk assessment and monitoring,
health-related lifestyles, and preventive medication [1].
Nevertheless, an international study in general practice,
which is the setting where many of these recommenda-
tions have to be implemented, showed room for improve-
ment of current practice [2, 3].
Tailored implementation seems a promising way to im-
prove CVRM. It is an approach in which determinants of
practice are prospectively identified, followed by system-
atic matching of strategies to the identified factors [4]. A
systematic review of 32 trials confirmed the positive im-
pact of tailored implementation interventions, but also
highlighted the uncertainty on the usefulness of different
methods for tailoring [5]. As part of a large, international
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study of tailored implementation, the Tailored Implemen-
tation for Chronic Diseases (TICD) project, we adopted
these strategies to CVRM in the Netherlands. In an inter-
view study, primary care professionals, patients, and other
stakeholders emphasized the challenges of counselling pa-
tients on health-related lifestyles, medication adherence,
and self-management [6–8]. We developed and evaluated
a tailored implementation program to address these chal-
lenges, based on a comprehensive empirical analysis of
determinants of delivering recommended CVRM and sug-
gestions for interventions. The aim of the present study
was to determine the effectiveness of the tailored imple-
mentation program on professional performance and out-
comes in cardiovascular prevention compared to usual
care in general practice. In the Netherlands, patient educa-
tion and counselling of cardiovascular patients is mainly
provided by practice nurses [9], so they were the primary
target of the improvement program.
Methods
Study design
An open-label, two-arm, cluster randomized trial was con-
ducted in the years 2013 and 2014 in the Netherlands
[10]. The study was part of the international TICD project
[11]. We performed block randomization of the participat-
ing general practices, stratifying for practice size (one
general practitioner versus two general practitioners or
a group practice) and practice location (rural versus
urban), using a computer program that was handled by
an independent researcher. The Medical Ethics Com-
mittee of Arnhem-Nijmegen waved approval for the
study (file 2013/229).
Samples
A random sample of general practices in seven geo-
graphical areas in the Netherlands was invited to partici-
pate in the study, resulting in a sample of 34 practices at
baseline. Figure 1 presents the flow of participants
through the study. In the participating practices, two
samples of patients were approached for participation in
the study: patients at high cardiovascular risk and pa-
tients with established CVD. These high risk patients
have an estimated 10-year risk score of 20 % or higher
for morbidity and mortality due to CVD. Patient selec-
tion was based on the following International Classifica-
tion of Primary Care (ICPC) codes: K74-K76, K85-K92,
K99.1, and T93. Patients had to be adults aged 18 or
older, have a high risk of CVD (but no known CVD) or
established CVD, and capable of providing informed
consent. Exclusion criteria were diabetes mellitus, preg-
nancy and lactation, terminal illness, cognitive impair-
ment, and poor language skills.
Implementation program
A tailored implementation program was developed in a sys-
tematic, stepwise process. We have reported on the various
steps in this developmental process before [6–8, 12]. First,
prevailing clinical guidelines [13, 14] and clinical audit data
were analyzed to define the following interrelated targets
for improvement: systolic blood pressure (SBP) <140 mmHg
in patients with established CVD or in patients at high
risk for CVD; low-density lipoprotein (LDL) cholesterol
<2.5 mmol/l in patients with established CVD or in pa-
tients at high risk for CVD; promote lifestyle changes
in patients with (high risk for) CVD; create a risk pro-
file for patients with chronic kidney disease.
Then, an interview study was done, involving physi-
cians, nurses, and patients, which identified 139 plaus-
ibly important determinants of practice (“barriers or
enablers of implementation”). Of this list, a set of 11
determinants was selected based on importance and
changeability as judged by the research team and used
for subsequent steps [8, 12]. Subsequently, group inter-
views with different stakeholders and patients gener-
ated 181 suggested strategies for implementation,
which were perceived to address the selected set of 11
most relevant determinants [6].
The research team discussed the large number of strat-
egies suggested. Physicians and nurses in Dutch general
practices expressed an interest in continued training of
their motivational counselling skills, although research
seemed to suggest little impact [15, 16]. They also
expressed an interest in using online information tools
for patients more actively in their patient counselling. As
depressive symptoms are an important moderator of pa-
tient counselling, the recommendations suggested ad-
dressing depressive symptoms first, before focusing on
health-related lifestyles or adherence to preventive drug
therapy. Considering feasibility and potential impact, the
research team selected the following implementation
strategies for this trial: structured feedback by profes-
sional trainers to practice nurses on their motivational
interviewing skills in practice (“refresher training”); ac-
cess to an online educational program on CVRM, which
was developed by the Dutch College of General Practi-
tioners; written guidance on relevant e-health options
for patients, emphasizing www.thuisarts.nl and harten-
vaatgroep.nl, and a planned Twitter consultation hour
for patients; and a flow chart for dealing with depressive
symptoms in cardiovascular patients. The last item was
an elaboration of the recommendation in the guideline
on cardiovascular risk management “to consider relevant
co-morbidities.” It suggested to treat major depression
before giving any lifestyle advice and to promote phys-
ical exercise rather than any other lifestyle in patients
with mild depressive symptoms. A detailed description
of the implementation program has been published in
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the study protocol [10]. General practices in the control
arm of the study provided usual care and were offered a
delayed intervention after the follow-up measurements
had been completed.
Measures
Two waves of measurements were done in each practice:
at baseline and at follow-up 6 months later. Data for this
paper were collected from computerized patient records
in the general practices and from a written survey in a
cohort of patients. Descriptive characteristics of partici-
pating practices and practice nurses were recorded with
a structured questionnaire, which was completed by
practice nurses.
A modified version of the validated EPA Cardio ab-
straction tool was applied to collect data from patient
records in participating general practices [17]. We
collected data on recorded patient counselling on
CVD-related lifestyle and on the presence of a record
of depressive symptoms in the intervention period and
actions related to that record. We recorded the latest
value if any of the SBP, the LDL cholesterol level, the
BMI and the smoking status in the intervention period,
and the latest value before the intervention period
started with a retrospective time window of 1 year. Fur-
thermore, we collected data on the presence of the fol-
lowing co-morbidities: asthma, COPD, and rheumatoid
arthritis.
Fig. 1 Flow chart of the study
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Patients received a paper-based questionnaire at inclu-
sion and at the end of the intervention period of
6 months. We asked for their highest level of education
as a proxy for social economic status. Furthermore, we
assessed the presence of depressive symptoms using the
Patient Health Questionnaire-9 (PHQ-9) [18]. Scores of
5, 10, 15, and 20 represent cut points for mild, moderate,
moderately severe, and severe depression, respectively.
Based on these cut points, we considered a score up to 5
as no depressive symptoms, 6 to 15 as mild depressive
symptoms, and a score above 15 as severe depressive
symptoms in our description of the patient sample.
Finally, we used the Rapid Assessment of Physical
Activity (RAPA; 9 items) [19] to assess patient’s phys-
ical activity level and the shortened Rapid Eating and
Activity Assessment (REAP-S; 12 items) [20] to assess
dietary habits.
Primary and secondary outcomes
In our international working group, coordinating the trials
in the countries collaborating, we decided to provide a
common primary outcome measure across all trials based
on the performance of the health care professional tar-
geted by the interventions. The pre-defined primary out-
come referred to the professional performance of practice
nurses and reflected adoption of recommendations for
personalized counselling and education of CVRM pa-
tients. We created a dichotomous score for measure-
ment in each patient, reflecting adequate or inadequate
performance. We considered practice nurses’ profes-
sional performance to be adequate when at least one of
the following two conditions was met: (1) there is a rec-
ord in the patient’s record that the patient has received
advice on at least one lifestyle item as specified in the
prevailing guidelines of CVRM: diet, smoking, or phys-
ical exercise. Also, at least one target for improving an
aspect of lifestyle is recorded. When a patient has a
perfect lifestyle, then that will be recorded. (2) There is
a notation in the patient’s record that the patient has
none, mild, or severe depressive symptoms and that the
patient has been referred to E-health, a physical exer-
cise group or depression treatment, respectively. If
there was no record, we considered that there was no
personalized counselling or education to the patient.
As secondary outcomes, we recorded the various ele-
ments contributing to the composite primary outcome:
the health care received by each patient (counselling on
lifestyle with personal goal setting, referral to a physical
exercise group, referral for depression treatment). Further-
more, as secondary outcomes, we documented blood
pressure (SBD <140), cholesterol levels (LDL <2, 5),
body mass index (BMI <25), smoking status (yes/no),
food intake (REAPS, range 1–3), and physical exercise
(RAPA, range 1–7).
Statistical power
The study was powered to detect a 15 % difference on
the primary outcome. For sample size calculation, we
used a web-based program [21], and based on previous
research, we assumed an intra-cluster correlation coeffi-
cient (ICC) of 0.05 [22, 23], alpha of 0.05, and a power
of 0.80. The calculation indicated that 450 patients per
group (high risk or established CVD) would be needed
(15 patients at high risk for CVD and 15 patients with
established CVD per cluster, sampled in 30 practices).
Assuming high risk patients often only visit the practice
once a year and that half of the CVD patients receive
specialist care, we doubled the numbers of patients for
inclusion. Furthermore, to allow for loss to follow-up,
we enlarged the inclusion with another 30 %.
Data analysis
Data were analyzed using SPSS (version 20, IBM Corp.)
and MLWIN (version 2.28). For all primary statistical tests,
two-sided hypothesis testing with an alpha level of 0.05
was applied. All data analyses were based on “intention to
treat.” For assessing effects on the outcomes, the interven-
tion and control group were compared regarding each of
the primary and secondary outcomes. In the study proto-
col, we planned to perform a chi-square test to assess the
primary outcome. However, we reconsidered this in favor
of a multilevel regression analysis to meet the highest ana-
lytical standards. The primary outcome was based on mea-
surements at follow-up only and therefore a two-level
model was used (patients nested in practices). We entered
group allocation (intervention/control) at practice level
and controlled for the following patient characteristics:
age, sex, education (low, medium, high), depressive symp-
toms (none, mild, severe), and co-morbidities (presence of
asthma, COPD, and/or rheumatoid arthritis). To test
for differences between the high risk and CVD patients,
we entered an interaction term with group allocation
(control/intervention) and patient group (high risk/
CVD). For the secondary outcomes with baseline and
follow-up measures, we used a three-level multilevel re-
gression model with measurements nested in patients,
and patients were nested in practices. Therefore, we
constructed the data in a long format and by including
an extra level, we controlled for differences in individ-
ual patients at baseline. We had planned to assess the
cardiovascular risk score in the high-risk patient group
and changes in these scores, but we had to refrain from
these analyses as not feasible.
Results
We invited 1600 practices to participate in our program;
initially, 48 responded that they wanted to participate.
Before group allocation and an introductory practice
visit, 4 practices withdrew, and after the initial practice
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visit, another 10 practices withdrew, 5 from both the
intervention and the control group. So, 34 practices en-
tered the study and included patients (Fig. 1). Two
practices in the intervention arm had two practices
nurses, all participating and being instructed; in both
the intervention arm and the control arm, one practice
nurse worked in two practices. No practices were lost
to follow-up. One practice nurse dropped out at the
end of the intervention period due to the fact that she
started to work in another practice but even from that
practice, we were able to retrieve data at the end of the
intervention period.
In total 2229 patients (41.8 % of those invited) gave in-
formed consent for the study in the baseline patient
questionnaire. In all groups (intervention and control,
high risk, and established CVD), men were about twice
as numerous as women. The high risk group patients
were about 75 years old, and the CVD patients just
under 70. In total, 75 % of the patients had no depres-
sion, about 23 % had mild depressive symptoms and 2 %
had a severe depression, based on the PHQ-9 question-
naire at baseline. Tables 1 and 2, respectively, display
some practice characteristics and patient characteristics
at baseline.
Primary outcome
We found no effect of our intervention on the primary
outcome of this study (see Table 3). A record proving
adequate practice nurse performance was present in
11.4 % of the patients in the intervention practices and
in 10.3 % of the patients in the control group. There was
in only six patients a record of depressive symptoms.
The element of this composed primary outcome meas-
ure related to physical exercise advice was more often
recorded in the intervention group (6.8 versus 3.7 %),
though in multilevel regression analysis, this proved to
be non-significant. The other components, too, showed
no differences.
Secondary outcomes
Regarding secondary outcomes, we found that physical
exercise showed a significant improvement in the inter-
vention group compared to the control group (see Table 4).
The RAPA score improved on a scale from 1 to 7 from
4.8 to 4.9; in the control group, the activity diminished
reflected in a score diminishing from 4.9 to 4.8 (effect size
B = 0.18 (0.02–0.35), p < 0.05). On the other cardiovas-
cular risk factors assessed (SBP, LDL cholesterol, smok-
ing status, BMI, and diet), the improvement program
had no significant effect. We found no difference in the
effect of the intervention between the high cardiovascu-
lar risk group and the group with established CVD.
However, CVD patients had their LDL cholesterol and
SBP level more often on target (OR 3.8, 95 % CI 2.9–5.1
and OR 1.5, 95 % CI 1.2–1.8, respectively).
Discussion
The tailored implementation program had no overall ef-
fect on counselling of cardiovascular patients (the pri-
mary outcome of the trial). However, we found an effect
on one secondary outcome: patients’ physical activity
level increased. The latter finding may suggest that the
messages on physical exercise, as recommended for pa-
tients with mild depressive symptoms, were picked up
by practice nurses and applied in daily practice. Never-
theless, overall, we conclude that the tailored implemen-
tation program was not effective.
There are several alternative explanations for the lack
of effects. In process evaluations, we will report on the
outcomes of interviews and questionnaires with prac-
tice nurses and a sample of patients, and on scoring of
knowledge and motivational interviewing skills [10, 24].
In general, we can hypothesize that failure of effective-
ness might be due to lack of relevance of determinants
or strategies, wrong prioritizing, or inadequate inter-
vention delivery. First, identified determinants of prac-
tice may be less relevant than perceived by stakeholders
or proposed interventions may be less helpful than ex-
pected. For instance, studies in general practice seemed
to suggest little effect of motivational interviewing (MI)
skills training [15, 16]. In the developmental phase of our
study, we held focus group discussions with various stake-
holders [7, 8] and interviewed them about suggestions for
interventions to address previous identified determinants of
practice. All stakeholder groups suggested motivational
interviewing training and participating primary care pro-
viders appreciated such training. Koelewijn et al. in the IM-
PALA study offered an improvement program providing
Table 1 Practice and practice nurse characteristics
Intervention group
(n = 19)
Control group
(n = 15)
19 practices with
20 practice nurses
15 practices with
14 practice nurses
Practice characteristics
Single-handed practice 10 9
Duo/group practice 9 6
Rural area 10 6
Urban area 9 9
Practice nurse characteristics
Mean age in years 42 43
Mean number of years
experience as practice nurse
12 11
Mean number of hours
previous training of
motivational interviewing
skills
14.7 14.8
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MI training to practice nurses [15]. Patients included
were at high cardiovascular risk without established
CVD. They could not prove the program to be effective.
Jansink developed and tested a program including MI
courses for diabetic nurses [16]. This program, too,
showed no improvement in their main outcomes. These
findings challenge the use of interviews and surveys
with stakeholders in tailored implementation as well as
the usefulness of motivational interviewing in the tar-
geted patient populations.
Second, numbers of both determinants of practice and
suggestions for improvement were high, so it is possible
that in our tailoring procedures, we did not prioritize
the right determinants in terms of importance and
changeability or the right interventions considering
feasibility and impact. For instance, we might have better
focused on practice nurses’ views on effective interven-
tions, as they were the primary receivers of the tailored
implementation program. Involvement of practice nurses
in selecting strategies in the development of the multifa-
ceted program might have been another method to as-
sure adequate choices in this phase.
Third, we may have chosen interventions adequately,
but not delivered them in the required intensity. For in-
stance, a short training session with feedback on two pa-
tient contacts may have been insufficient to effectively
improve counselling skills. Some of the information
technology tools were innovative, so it may be too early
Table 2 Description of patient sample at baseline
Intervention group (n = 1250) Control group (n = 979)
Total Patients with high
cardiovascular risk
Patients with
cardiovascular disease
Total Patients with high
cardiovascular risk
Patients with
cardiovascular disease
Women (%) 35.1 32.1 38.4 34.9 31.7 38.5
Mean age (SD) 72.6 (9.7) 75.1 (6.4) 69.6 (11.8) 71.6 (9.7) 74.0 (6.5) 68.9 (11.7)
Education low (%) 39.8 38.3 41.6 43.0 42.0 44.0
Education medium (%) 31.7 30.7 32.8 32.1 30.0 34.5
Education high (%) 28.5 31.0 25.6 24.9 28.0 21.5
Hypertension (%) 59.9 67.7 51.1 59.2 65.6 52.0
Hypercholesterolemia (%) 18.4 16.6 20.4 20.2 16.1 24.8
BMI >25 (%) 30.2 29.4 31.3 30.6 29.3 32.4
Recorded smokers (%) 10.4 7.2 13.8 10.5 8.9 12.2
Other chronic disease (%) 14.8 12.9 16.9 14.5 13.0 16.0
No depression (%) 74.4 79.2 68.8 75.6 85.4 64.9
Mild depression (%) 23.6 19.1 28.7 22.7 13.6 32.7
Severe depression (%) 2.0 1.7 2.5 1.7 1.0 2.4
Table 3 Primary outcomes: medical audit data on patient counselling
Intervention arm Control arm OR (95 % CI)
(n = 995 patients) (n = 787 patients)
% (n) % (n)
Number of patients who received recommended counselling
(=primary outcome measure)
11.4 (113) 10.3 (81) 1.11 (0.56–2.21)
In subgroup of patients with high cardiovascular risk 11.9 (63) 12.0 (47) 1.00 (0.42–2.38)
In subgroup of patients with cardiovascular disease 10.7 (50) 8.6 (34) 1.27 (0.68–2.38)
Recorded physical exercise advice/goal 6.8 (68) 3.7 (29) 1.85 (0.68–5.04)
Recorded stop-smoking advice 1.4 (14) 1.5 (12) 1.07 (0.43–2.64)
Recorded diet advice 7.9 (78) 7.8 (61) 0.95 (0.39–2.31)
Recorded goal for lifestyle change in patients with no record of depressive symptoms (99.6 %) 11.3 (112) 10.2 (80) 1.10 (0.55–2.17)
Recorded physical exercise advice or referral in mild depressed patients (relates to 6 patients) 0.1 (1) 0.0 (0) NA
Recorded depression treatment or referral in severe depressed patients (relates to 1 patient) – 0.1 (1) NA
NA not assessed
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to implement these effectively or more time might be
needed. Finally, the presence of a practice nurse with
some education in counselling techniques was an inclu-
sion criterion for practices as we intended to provide a
refresher course instead of a complete course. So, the
practice nurses in the control group were somehow
skilled thus reducing the potential for improvement by
the tailored program.
Another explanation of the poor results may relate to
the level of tailoring. In our international project, we had
clearly defined and separate steps in the developmental
phase of the intervention program. For that reason, we
collected information on determinants of practice and
suggestions in groups of stakeholders. These groups com-
prised health care professionals finally targeted but not
those from the practices that participated in our trial. In
another setting, the tailoring could be on a higher level,
i.e., on the level of the practices or health care profes-
sionals participating with adjustments. Then, we would
have researched the determinants within the practices par-
ticipating and searched for strategies specifically suitable
and tailored per practice. In the process evaluation, we will
report on the practice nurses’ opinion on the determinants
addressed and the interventions offered [21].
We found an overall low score on practice nurse per-
formance in our primary outcome as measured by the
results of the chart audit. The maximum feasible score
for this outcome is unknown but definitely not 100 %. In
general, the high risk patients pay a CVRM-related visit
to the practice only once a year and a proportion of the
patients with established CVD is treated in secondary
care. Nevertheless, considering the fact that a large
group of about half of the patients did not visit the prac-
tice for CVRM in the intervention period and was not
exposed to the intervention, the low scores still suggest
room for improvement. Poor documentation may add to
the low score on the primary outcome. In the introduc-
tion and instruction of the project, we emphasized the
importance of good registration. The relevance of mak-
ing record notes in the explanation of the trial results
will be part of the process evaluation.
The positive effect on one of our secondary outcome
measures relates to physical activity. We advised to refer
patients with mild depressive symptoms to physical ac-
tivities as these are beneficial for both the cardiovascular
risk profile and depressive symptoms. As such, in our
program delivery, we had extra attention for physical ex-
ercise, more than for other lifestyle issues. Without a
record of depressive symptoms, more patients had a rec-
ord of advice on physical activity with a personal goal.
Apparently, this lifestyle issue gained more attention in
the intervention group. Recording advice, a process indi-
cator, improved non-significant. The related patient out-
come “physical activity” improved significantly which
makes it more plausible that this effect is not related to
chance.
The study was designed to enhance internal validity
as well as reflect routine clinical practice, but it also
had a number of limitations. Interviews with stake-
holders were used to identify determinants of practice
and suggestions for interventions, but it is difficult to
assess the validity of this method. Stakeholder involve-
ment in the design of interventions may in fact have
served a different purpose, which is enhanced accept-
ability of the program for the targeted health care pro-
viders. The generalizability of findings may be limited
by the low recruitment rate, although it seems unlikely
that more effects would have been achieved in non-
participants. Surveys were planned at baseline and
6 months later, but this was only partly achieved. Due
to practical constraints, patients’ questionnaires were
sent out up to 2 months later. Note however that most
outcomes, including the primary outcome, were based
on chart audits taking into account the start date of
the intervention period. As the study was a pragmatic
trial, we cannot rule out the possibility that external
influences have had impact on the outcomes. In the
field of cardiovascular primary care, changes in the re-
imbursement and quality management may have im-
pacted on practices in both intervention and control
arms of the study diluting possible effects of our
program.
Table 4 Secondary outcomes: risk factors (medical audit data and patient questionnaires)
Intervention arm Control arm
Baseline Follow-up Baseline Follow-up B/OR (95 % CI)
Physical exercise (RAPA, 1–7) 4.8 (1.60) 4.9 (1.52) 4.9 (1.59) 4.8 (1.53) B 0.18* (0.02–0.35)
Diet (REAP-S, 1–3) 2.2 (0.38) 2.3 (0.37) 2.2 (0.38) 2.2 (0.37) B 0.03 (0.00–0.07)
Smoking (%) 10.3 10.4 12.5 10.5 OR 1.11 (0.68–1.82)
BMI <25 (%) 29.5 30.2 26.3 30.6 OR 0.84 (0.48–1.46)
LDL <2.5 (%) 30.5 32.3 26.6 31.2 OR 0.85 (0.53–1.38)
SBP <140 (%) 57.6 56.9 57.9 57.1 OR 1.03 (0.72–1.48)
B regression coefficient, OR odds ratio
*p < 0.05
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Conclusions
For tailoring an intervention, we recommend including a
systematic method for assessment and prioritization of
determinants of practice and suggested implementation
interventions. The program may benefit from more at-
tention for the targeted group, the practice nurses in our
program. On the basis of the findings of this trial, we
cannot recommend broad implementation of the tested
improvement program. In a process evaluation of the
trial, we will explore the impact of interventions on the
addressed determinants of practice [10]. This will pro-
vide further insight into the validity of the interview
methods, which were used in the development of the
implementation program. Our process evaluation and fu-
ture research may elucidate whether attention on physical
activity could be a key target for future programs to im-
prove cardiovascular prevention. Future studies should ex-
plore alternative methods for tailored implementation,
such as theory-orientated approaches or different stake-
holder involvement methods.
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